Dakota Wealth Management Cuts Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Dakota Wealth Management reduced its stake in Intuitive Surgical by 43.6% during the second quarter, selling 10,043 shares and leaving them with 12,983 shares valued at approximately $7.06 million.
• Several institutional investors increased their stakes in Intuitive Surgical, with Chilton Capital Management raising its stake by 614.3% and TD Capital Management increasing theirs by 300.0% in the first quarter.
• Wall Street analysts have mixed ratings on Intuitive Surgical, with an average target price set at $595.95, and thirteen analysts rating the stock as a "Buy."

Dakota Wealth Management decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 43.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,983 shares of the medical equipment provider's stock after selling 10,043 shares during the period. Dakota Wealth Management's holdings in Intuitive Surgical were worth $7,055,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Chilton Capital Management LLC increased its stake in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 43 shares during the last quarter. Global Financial Private Client LLC raised its holdings in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical during the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA purchased a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. Finally, TD Capital Management LLC raised its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 45 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Truist Financial increased their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Wells Fargo & Company increased their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Stock Down 0.8%

NASDAQ:ISRG opened at $443.99 on Thursday. The stock has a market cap of $159.16 billion, a P/E ratio of 61.92, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The firm's fifty day simple moving average is $472.54 and its 200 day simple moving average is $502.13. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the business posted $1.78 earnings per share. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.